U.S. markets closed

Repligen Corporation (RGEN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
251.35+4.86 (+1.97%)
At close: 04:00PM EDT
250.03 -1.32 (-0.53%)
After hours: 06:36PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close246.49
Bid120.00 x 800
Ask300.00 x 900
Day's Range243.08 - 251.62
52 Week Range137.21 - 327.32
Avg. Volume536,985
Market Cap13.948B
Beta (5Y Monthly)1.06
PE Ratio (TTM)94.49
EPS (TTM)2.66
Earnings DateOct 26, 2022 - Oct 31, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est266.56
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Near Fair Value
28% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for RGEN

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Repligen Corporation
    RGEN: Raising target price to $173.00REPLIGEN CORP has an Investment Rating of HOLD; a target price of $173.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Medium.
    Fair Value
    Economic Moat
    2 months agoArgus Research
View more